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Abstract
Obesity and infectious agents are both sources of inflammatory stimuli that result in increased production of C-reactive
protein (CRP). Rates of overweight and obesity are increasing globally, but for many populations, gains in body fat are set
against a backdrop of high levels of pathogen exposure. Our primary objective was to evaluate the extent to which adiposity
and pathogenicity contribute to a double burden of inflammation in a population currently undergoing the nutrition transition.
Measures of adiposity, pathogen exposure, and infectious disease symptoms were evaluated as predictors of high-
sensitivity CRP concentration in plasma samples from 1875 women participating in the Cebu Longitudinal Health and
Nutrition Survey in the Philippines. Proxy measures of pathogen exposure included household crowding and cleanliness,
quality of water source, mode of waste disposal, and fecal exposure. A series of maximum likelihood logistic regression
models were used to predict a plasma CRP concentration . 3 mg/L. Waist circumference was the strongest anthropometric
predictor of elevated CRP [odds ratio (OR) ¼ 2.29; 95% CI ¼ 2.00, 2.62; P , 0.001]. Presence of infectious disease
symptoms (OR¼ 2.51; 95% CI¼ 1.84, 3.44; P , 0.001) and level of pathogen exposure (OR¼ 1.56; 95% CI¼ 1.15, 2.12;
P , 0.01) were also associated with elevated CRP. These associations were independent of socioeconomic status and other
health behaviors. Overweight/obesity and infectious exposures are associated with elevated CRP in the Philippines; it is
likely that other populations undergoing the nutrition transition are experiencing comparable double burdens of inflammatory
stimuli. These results underscore the need for additional research on the contributions of pathogenicity, adiposity, and
inflammation to global epidemics of cardiovascular and metabolic diseases. J. Nutr. 138: 2442–2447, 2008.
Introduction
Chronic degenerative diseases have recently superseded nutri-
tional deficiencies and infectious diseases as the primary causes
of morbidity and mortality worldwide (1,2). Whereas classic
epidemiologic transition theory postulates that rising rates of
communicable diseases are preceded by declines in infectious
disease (3), many populations in less developed countries are
now confronting a double burden of disease in which rapidly
rising rates of obesity and associated metabolic conditions are
supplementing rather than supplanting infectious diseases as
contributors to morbidity and mortality (4–6). Obesity and
pathogen exposure are both involved in activating proinflam-
matory pathways and we investigated these factors as predictors
of plasma C-reactive protein (CRP)6 to evaluate whether women
in the Philippines are experiencing a double burden of inflam-
mation as a result of the nutrition transition.
The development of high sensitivity assays has revealed that
slight elevations in CRP, indicating chronic, low-grade inflam-
mation, are associated with subsequent incidence of cardiovascu-
lar disease (7), type 2 diabetes (8), the metabolic syndrome (9),
late-life disability (10), and mortality (11). This rapidly growing
literature has drawn attention to the important role that inflam-
matory processes may play in the pathophysiology of a wide range
of chronic diseases (12). Even as uncertainty remains about the
causal role of CRP in the pathophysiology of chronic disease
processes and outcomes, the value of CRP as a marker of risk has
been widely demonstrated and it is increasingly being used in
routine clinical practice (13).
In light of the roles played by infectious agents (14–17) as
well as adipose tissue (18–20) in upregulating inflammatory
pathways, populations undergoing the nutrition transition may
be particularly vulnerable to metabolic and cardiovascular dis-
eases linked to inflammation. The Philippines is a lower-middle
income nation undergoing considerable economic, dietary, and
lifestyle changes, and it exemplifies current trends toward ris-
ing prevalences of overweight, cardiovascular disease, and the
metabolic syndrome globally (21,22). At the same time, infec-
tious disease accounts for over 30% of all mortality in Southeast
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Asia, with pneumonia, diarrhea, and tuberculosis serving as
major contributors (23). In the Philippines, respiratory infec-
tions rank beside ischemic heart disease as the top causes of
mortality (24).
This pathogen burden, in combination with the potential
impact of recent increases in body weight, provides an opportu-
nity to investigate the predictors of inflammation in a population
confronting double burdens of disease. Furthermore, because
overweight is positively related to socioeconomic status (SES) in
Cebu (21) (unlike the US and other affluent nations) and because
we expect exposure to pathogens to be negatively related to SES,
we are in a better position to disentangle the independent roles
that adiposity and pathogen exposure may play in predicting
inflammation. Our specific objectives in this article are 3-fold: 1)
to document concentrations of CRP in Filipino women undergo-
ing the nutrition transition; 2) to investigate associations between
CRP and both anthropometric measures of nutritional status as
well as proxy measures of pathogen exposure; and 3) to evaluate
the extent to which adiposity and pathogenicity contribute to a
double burden of inflammation in this population.
Subjects and Methods
Participants and data collection. The Cebu Longitudinal Health and
Nutrition Survey began in 1983 with the recruitment of 3327 pregnant
women representative of the childbearing population in Cebu City (25).
The women have been followed through multiple rounds of data
collection since 1983 and the data for the present analyses come from
the most recently completed survey, conducted in 2005, when the
women were 35–69 y. Complete anthropometric, environmental, socio-
demographic, and CRP data were available for 1875 women (6 women
who were pregnant at the time of survey were excluded). Participants
provided information on household demographics and income levels,
economic activities and resources, environmental quality, and health
behaviors in personal interviews conducted in their homes. All data were
collected under conditions of informed consent with institutional review
board approval from the University of North Carolina, Chapel Hill.
We evaluated how our sample differed from the original cohort as
assessed when the study started in 1983. Compared with those lost to
follow-up, participants remaining in the study were significantly older
(6.61 6 2.50 mo), had less formal education (0.86 6 0.13 y), lower
household income (0.06 6 0.01 log pesos) and number of household
assets (0.19 6 0.07 items), and lived in slightly more rural communities
(3.65 6 0.43 points on urbanicity scale, see below). Participants did not
differ in height at baseline or in other household traits.
Body weight, height, waist and hip circumferences, and triceps,
subscapular, and suprailiac skinfold thicknesses were measured using
standard anthropometric techniques (26). The BMI was calculated as the
ratio of weight (kg):height (m2).
Following prior research in the Philippines and elsewhere (27–29),
we collected multiple measures of environmental quality as proxies for
the likelihood of exposure to infectious microbes. Measures included
household crowding (number of persons per number of rooms), type of
toilet (no toilet, pit, flush/water sealed), and source of drinking water
(bottled, piped municipal supply, closed well with pump, open sources:
uncovered well, spring, river, rain). We also constructed a pathogen
exposure scale based on 5 variables, each scored on a 3-point scale (0 ¼
low exposure, 1 ¼ moderate, 2 ¼ high): cleanliness of the food prep-
aration area, means of garbage disposal, presence of excrement near the
house, level of garbage, and excrement present in the neighborhood
surrounding the household. Cronbach’s a for the scale was 0.741,
suggesting a relatively high degree of reliability. Low correlations be-
tween these variables and our measures of household density, toilet type,
and water access precluded the construction of a single summary
pathogenicity scale. Prior analyses in the Cebu Longitudinal Health and
Nutrition Survey have documented significant associations between
comparable measures of environmental quality and risk for infant
diarrhea, attesting to their utility as proxies for pathogen exposure (29).
In addition to measures of pathogen exposure, at the time of blood
collection, we asked participants if they were currently experiencing any
symptoms of infection, consistent with prior research on CRP (30,31).
Symptoms included runny nose, cough, fever, diarrhea, and sore throat, as
well as the more general categories of flu, cold, and sinusitis. Responses
were used to construct a summary variable indicating the presence or
absence of any infectious symptoms at the time of blood collection.
Participants were also asked to report any medications they were currently
taking. Only 16% of the sample reported taking medications at the time of
blood collection, and we considered5 broad categories of medications with
potential relevance to CRP: oral contraceptives, antihypertensives, anti-
biotics, cough and cold remedies, and antiinflammatory analgesics. No
other types of medication were reported with sufficient frequency for
analysis. Individuals reportingsymptoms of infectionweremore likely tobe
taking antibiotics (Pearson x2 ¼ 67.5; P , 0.001) or cough/cold remedies
(Pearson x2 ¼ 359.6; P , 0.001), suggesting that these reports were
capturing the experience of infectious symptoms in this population.
In an attempt to capture other unmeasured aspects of environmental
quality and lifestyle that may be related to CRP, we considered 4 mea-
sures of SES: highest grade completed, household income, household
assets, and home ownership. We also used a previously validated mea-
sure of the degree of urban development in the community in which
participants lived (32). This scale is based on population size and density,
availability of communications (e.g. telephone, Internet), transportation
infrastructure, and presence of educational facilities, health services, and
markets for food and other consumer goods. Higher scores (range, 0–70)
on the scale indicate a higher degree of urban development.
CRP analysis. Venipuncture blood samples were collected using EDTA-
coated vacutainer tubes in the participants’ homes in the morning after
an overnight fast. Blood samples were kept in coolers on ice packs for no
more than 2 h and were then centrifuged to separate plasma prior to
freezing at 270C. Samples were express-shipped in a single batch
to Northwestern University on dry ice and stored frozen at 280C
until analysis. CRP concentrations have been shown to remain stable
under these transport and storage conditions (33). CRP concentrations
were determined using a high sensitivity immunoturbidimetric method
(Synchron LX20, lower detection limit: 0.1 mg/L).
Statistics. We performed a series of maximum likelihood logistic
regression analyses to predict, first, the likelihood of CRP .10 mg/L and
then CRP .3 mg/L, excluding those individuals with CRP .10 mg/L.
These cut-off values were selected based on recommendations issued by
a recent joint scientific statement from the AHA and the CDC (13).
Concentrations of CRP .10 mg/L are presumed to be the result of acute
inflammatory processes (e.g. infectious disease), whereas elevations of
CRP .3 mg/L but ,10 mg/L indicate increased cardiovascular risk due to
chronic, low-grade inflammation. Recent research, however, has suggested
that CRP concentrations .10 mg/L are also predictive of cardiovascular
risk (34). We therefore conducted a final series of analyses predicting the
likelihood of CRP .3 mg/L in the entire sample. In addition, we used
Pearson product-moment correlation coefficients to investigate bivariate
associations among BMI, SES, and pathogen exposure.
Analyses proceeded in 3 stages. First, we considered anthropometric
measures of nutritional status as predictors of elevated CRP. We began
with crude associations, followed by models that adjusted for additional
factors known to influence CRP (age, smoking, alcohol consumption,
medication use). Adjusted models also included measures of SES and
urbanicity in an attempt to account for omitted variables related to
lifestyle and/or environmental quality that might confound associations
between CRP and our more proximate measures of nutritional status and
pathogenicity. Second, in a separate set of models, we evaluated crude
and adjusted associations with measures of pathogen exposure and
infectious disease. Finally, we considered a combined model with signi-
ficant nutritional status and pathogenicity variables to evaluate their
independent and combined contributions to explaining elevated CRP. All
statistical analyses were conducted with Stata for Windows, version 10
(StataCorp). We used a , 0.05 as the criterion for significance. Values in
the text are means 6 SEM or odds ratio (OR), 95% CI.
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Results
The median CRP concentration was 0.9 mg/L (Table 1). Mean
BMI was 24.3 kg/m2, with 41.4% of the sample classified as
overweight or obese according to WHO criteria [BMI $25;
(35)]. Applying lower BMI cut-points recommended for Asian
populations [$23; (36–38)] increased the prevalence of over-
weight/obesity to 59.5%. As expected, measures of SES were
positively associated with BMI, including household income (r¼
0.21; P , 0.001), highest completed grade (r¼ 0.16; P , 0.001),
and household assets (r ¼ 0.29; P , 0.001). Similar associations
were also found with other anthropometric measures of adi-
posity. Conversely, socioeconomic measures were negatively
related to scores on our pathogen exposure scale, including
household income (r ¼ 20.08; P , 0.001), highest completed
grade (r ¼20.10; P , 0.001), and household assets (r ¼20.22;
P , 0.001).
Eighty-four women, or 4.5% of the sample, had concentrations
of CRP .10 mg/L. Age (1.04, 1.00, 1.07; P , 0.05), the presence
of infectious disease symptoms at the time of blood collection
(2.66, 1.65, 4.26; P , 0.001), and living in a more urban
environment all predicted CRP .10 mg/L (1.27, 1.01, 1.61; P ,
0.05). No anthropometric, socioeconomic, or other pathogenicity
variables approached significance as predictors of CRP .10 mg/L.
We next modeled the likelihood of CRP .3 mg/L, excluding
the 84 women with CRP .10 mg/L. Twenty percent of the
sample (n ¼ 352) had CRP .3 mg/L and #10 mg/L. Each
anthropometric measure of body composition was significantly
associated with increased CRP, but waist circumference was the
strongest predictor and the only one that remained significant
when measures were considered simultaneously (Table 2, Model
1). This association was independent of age, smoking, house-
hold income, use of antiinflammatory analgesics, and neighbor-
hood urbanicity, all of which were positively associated with
elevated CRP. Other medication variables were not associated
with CRP. The association between waist circumference and
CRP was not substantially altered by the addition of these
covariates. Controlling for these variables, each SD increase in
waist circumference was associated with a .1-fold increase in
risk of CRP .3 mg/L.
Variables representing pathogen exposure and symptoms of
infection were significantly associated with elevated CRP, even
though individuals with CRP .10 mg/L were eliminated from the
analyses. The presence of symptoms of infectious disease at the
time of blood collection was a strong predictor of CRP .3 mg/L,
as was our pathogen exposure scale (Table 2, Model 2). Similar
patterns of association were found for each of the variables
comprising the summary scale. Household density and the pres-
ence of a flush toilet were not associated with CRP.
Our measure of water quality was also associated with elevated
CRP. Compared with women whose households used bottled
water for consumption, those that relied on open sources (uncov-
ered well with bucket, spring, river, or rain) were less likely to have
elevated CRP. This association was contrary to expectation and
was attenuated slightly with the addition of household income to
the model. Associations between other measures of pathogen
exposure/infection and CRP remained unchanged with the addi-
tion of covariates.
Finally, we evaluated simultaneously measures of adiposity
and pathogen exposure as predictors of elevated CRP (Table 2,
Model 3). Waist circumference, symptoms of infectious disease,
and pathogen exposure remained as strong, independent pre-
dictors of elevated CRP. The addition of waist circumference
(which is positively associated with SES) eliminated the associ-
ation between CRP and water quality. Household income was
not significantly associated with elevated CRP in the full model.
Smoking, as well as residence in neighborhoods with a higher
degree of urban development, was also positively associated
with elevated CRP.
Results were very similar when models were rerun including
women with CRP .10 mg/L (results not shown). Smoking was an
exception and was not significantly associated with CRP .3 mg/L
when all women were considered.
We calculated the predicted probability of CRP .3 mg/L
based on regression coefficients (Table 2, Model 3) to evaluate
the magnitude of the independent associations among CRP,
waist circumference, and pathogen exposure (Fig. 1A). Variables
were set to low and high levels and individual values were
retained for other covariates. For women with waist circumfer-
ence1SDaboveaverage, thepredictedprobabilityofCRP.3mg/L
was 0.30 compared with 0.08 for women 1 SD below average.
Living in a high-pathogen household environment or having
symptoms of infection were associated with similarly high prob-
abilities of elevated CRP.
We next considered 4 scenarios representing the double
burden of inflammation (Fig. 1B). Our model (Table 2, Model
3) predicted that the probability of elevated CRP was 0.08 for
women in Cebu who live in low-pathogen environments and who
are 1 SD below average for waist circumference. For women with
low pathogen exposure but high waist circumference, the prob-
ability of elevated CRP more than tripled to 0.29. This scenario is
roughly comparable to that common for many women in affluent
western settings and, indeed, approximately one-third of women
in the US have CRP concentrations .3 mg/L (and ,10 mg/L) (39).
For women in Cebu with low waist circumference but high
pathogen exposure, a scenario common in Cebu until the onset of
the nutrition transition, the predicted probability of elevated CRP
was 0.12. Double burdens of inflammatory stimuli, represented
by high waist circumference and high pathogen exposure,
increased the probability of elevated CRP to 0.42. This scenario
may be more common as rates of overweight and obesity increase,
whereas levels of environmental contamination remain high. In
this sample, nearly 40 percent of all women resided in households
where moderate or high levels of excrement were visible near the
house.
Discussion
Dual burdens of chronic degenerative as well as infectious dis-
eases are increasingly common in many populations around the
world. In this study, we found that measures of body fat and
pathogen exposure were significant, independent predictors of
elevated CRP in women in the Philippines. These results suggest
TABLE 1 Descriptive statistics for study participants1
Age, y 47.7 (6.1)
Household income, pesos/wk 574.4 (1200.1)
Highest grade of school completed 7.2 (3.8)
Household assets, 0–11 5.2 (1.9)
BMI, kg/m2 24.3 (4.4)
Waist circumference, cm 81.1 (10.9)
Pathogen exposure scale, 0–2 0.6 (0.4)
Symptoms of infection, % 16.8
Current smoker, % 16.1
CRP, mg/L 0.9 (0.3, 2.8)
1 Values are mean 6 SD, median (25th percentile, 75th percentile) or %, n ¼ 1875.
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that a double burden of inflammatory stimuli may be an im-
portant component of the nutrition transition in similar popu-
lations, with potential implications for understanding patterns
of chronic degenerative disease globally.
In Cebu, SES is positively associated with overweight/obesity
but negatively associated with pathogen exposure. Socioecono-
mic factors were not strong predictors of CRP in this population,
likely due to the opposing influences that as SES increases, higher
levels of overweight/obesity can be expected to promote CRP
production, whereas cleaner household and neighborhood envi-
ronments should reduce CRP production. These results confirm
that Cebu is an advantageous setting in which to disentangle the
independent contributions of adiposity and pathogenicity to
variation in CRP, complementing findings from more affluent
settings where exposure to pathogens and excess body fat are
both likely to be concentrated in lower socioeconomic strata.
Using a BMI cut-off of 25 kg/m2, 41.4% of women in Cebu
were overweight or obese compared with 50.7% of European-
American women in the US according to recent estimates from
the NHANES (40). However, median CRP concentrations were
substantially lower among women in Cebu than in their U.S.
counterparts. For example, the median CRP concentration for
European-American participants in the Women’s Health Study
(n ¼ 24,455) was 2.02 mg/L (41) compared with 0.9 mg/L in
Cebu. Interestingly, median CRP concentrations for Asian-
American women in this U.S. sample were significantly lower
(1.12 mg/L) and similar to the values reported here. Low CRP
concentrations in Asian-American women in the Women’s
Health Study were explained largely by the relatively lower
BMI in this group (mean ¼ 23.4 kg/m2).
Similar to prior findings from a wide range of populations
(20,42–44), waist circumference was the strongest anthropom-
etric predictor of elevated CRP and among the strongest
predictors of all the variables considered. These results are
consistent with the established importance of visceral adipose
tissue (VAT) as a source of proinflammatory cytokines. Although
we did not measure VAT directly, waist circumference provides a
more specific measure of central adiposity than do measures
such as weight or BMI. VAT may be a particularly important
source of inflammatory stimuli in this population, because prior
research suggests that Filipino women have a higher proportion
of VAT compared with European- or African-American women
with the same level of waist circumference (45).
Intensity of pathogen exposure and symptoms of infectious
disease were independent predictors of elevated CRP, consistent
with the hypothesis that Filipino women are currently experi-
encing double burdens of inflammatory stimuli. The presence of
excreta, unsanitary means of garbage disposal, and an unhy-
gienic food preparation area were all associated with increased
risk for elevated CRP. Further, prior research has associated
proxy measures of sanitation/pathogen exposure with elevated
concentrations of CRP (46, T. W. McDade, S. T. Lindau, and
K. Kasza, unpublished results), although few studies using
high sensitivity CRP as an indicator of chronic, low-grade
inflammation consider such measures. Rather, most prior work
has followed recent guidelines (13) and excluded individuals
FIGURE 1 Probability of elevated CRP in relation to inflammatory
stimuli: independent associations with waist circumference, pathogen
exposure, and infectious symptoms (A) and cumulative associations
representing double burdens of inflammatory stimuli (B). Values are
predicted probability of CRP .3 mg/L for the entire sample (excluding
individuals with CRP .10/mg/L) based on coefficients from Table 2,
Model 3, with upper bound of 95% CI, n ¼ 1791. Low and high values
for predictors were set as follows: waist circumference (61 SD);
pathogen exposure (#1, .1); infectious symptoms (0, 1).
TABLE 2 Results of maximum likelihood models predicting the likelihood of CRP .3 mg/L, excluding individuals with
CRP .10 mg/L
Model 1 Model 2
Crude Adjusted Crude Adjusted Model 3
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Waist circumference, standardized 2.29*** 2.01, 2.61 2.22*** 1.94, 2.53 2.29*** 2.00, 2.62
Pathogen scale, 0–2 1.48** 1.12, 1.94 1.49** 1.10, 2.00 1.56** 1.15, 2.12
Infectious symptoms, 0, 1 2.18*** 1.64, 2.89 2.23*** 1.67, 2.99 2.51*** 1.84, 3.44
Water source1
Piped municipal supply 0.70* 0.51, 0.96 0.67* 0.47, 0.94
Closed well with pump 0.55** 0.39, 0.78 0.64* 0.45, 0.93
Open sources 0.29*** 0.17, 0.49 0.47* 0.27, 0.85
Age, y 1.03* 1.01, 1.05 1.03* 1.01, 1.05 1.03** 1.01, 1.05
Current smoker, 0, 1 1.59** 1.14, 2.23 1.48* 1.05, 2.09
Antiinflammatory analgesics, 0, 1 2.55* 1.09, 5.95 2.94* 1.27, 6.77 2.45* 1.05, 5.72
Household income, log pesos 1.54* 1.07, 2.21
Urbanicity, 0–70 1.02** 1.01, 1.03 1.02** 1.01, 1.03 1.01* 1.00, 1.02
Model P-value ,0.001 ,0.001 ,0.001
1 Bottled water is the reference group.
* P , 0.05; ** P , 0.01; *** P , 0.001.
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with CRP .10 mg/L in an effort to control for acute inflam-
matory conditions.
Contrary to expectations, household consumption of bottled
water was associated with elevated CRP. Bottled water is costly
and the pattern of results suggests that our water source measure
was functioning primarily as a proxy for SES rather than
pathogen exposure. This interpretation is supported by the fact
that Table 2 shows a graded association between water source
and odds of elevated CRP that parallels the association between
water source and SES. In addition, prior microbiological ana-
lyses of water quality in Cebu suggest that moderate levels
of bacterial contamination are not associated with increased
prevalence of infant diarrhea compared with low levels of
contamination and that other routes of pathogen transmission
are likely to be more important in this area (47).
Recent analyses of NHANES data have shown that symp-
toms of infection increased the likelihood of CRP .10 mg/L by
77% (30). Infectious symptoms explained a substantial portion
of the association between poverty and high CRP in this
analysis, although infection was not a strong predictor of more
modest elevations of CRP (.3 but #10 mg/L). This pattern of
results underscores the importance of pathogen pressure and
infectious disease as determinants of variation in CRP and
suggests that cut-off points based on Western reference popu-
lations may not be appropriate for populations experiencing
double burdens of inflammatory stimuli. It also suggests that
investigators need to consider carefully whether individuals with
CRP .10 mg/L should be eliminated from their analyses and
that serious attention should be given to quantifying pathogen
exposure in epidemiological analyses of inflammation.
To the extent that inflammation contributes to the patho-
physiology of cardiovascular or metabolic disease, CRP may be
an important mediator of the link between the recent increase in
obesity prevalence in the Philippines and rising rates of chronic
degenerative diseases (21,48). It remains an open question
whether upregulation of inflammatory pathways due to patho-
gen exposure or infection acts independently or synergistically
with adiposity in the etiology of cardiovascular disease in Cebu.
Indeed, it is possible that increased production of CRP in
response to pathogen exposure is part of a distinct inflam-
matory process that does not contribute to cardiovascular
disease. High levels of pathogen exposure early in life shape the
regulation of immune and inflammatory pathways (49,50) and
may have implications for the association between CRP and
cardiovascular disease later in life. However, studies demon-
strating associations among infectious agents, elevated CRP
concentration, and atherosclerosis suggest the possibility of
causal links between pathogen-induced inflammation and the
development of disease (14,17). Additional prospective research
on the implications of infectious exposures as well as over-
weight/obesity for the development of cardiovascular disease in
populations like the Philippines will be required to address this
issue.
A limitation of this study is our use of a single CRP result to
indicate chronic, low-grade inflammation. Whereas serial CRP
measurements have reported a relatively high degree of intra-
individual consistency that is comparable to other serum
markers of cardiovascular disease risk, multiple measures as
well as measures of other biomarkers of inflammation would
provide a more complete and accurate assessment of individual
differences in inflammatory activity (13,51,52). In addition, our
symptom recall method for assessing current infection lacks
specificity that may be relevant to CRP; latent infections, with no
overt symptoms, may increase concentrations of CRP, whereas
symptoms associated with allergic reactions may lead to the
appearance of infection without increasing CRP production.
This study casts new light on the dynamics of inflammation
by focusing on a location where the ecology differs significantly
from the relatively affluent settings in which most research
on high sensitivity CRP is conducted. Pathogen exposure and
adiposity are both important predictors of CRP in Cebu and
other populations undergoing the nutrition transition are likely
experiencing similar double inflammatory burdens. Our results
suggest that caution is in order when generalizing findings across
these settings and underscore the need for additional research
on the contributions of pathogenicity, adiposity, and inflamma-
tion to the global epidemic of cardiovascular and metabolic
diseases.
Literature Cited
1. WHO. World health report 2003: shaping the future. Geneva: WHO;
2003.
2. Popkin BM, Gordon-Larsen P. The nutrition transition: world-
wide obesity dynamics and their determinants. Int J Obes. 2004;28:
S2–9.
3. Omran AR. The epidemiologic transition: a theory of the epidemiology
of population change. Milbank Mem Fund Q. 1971;49:509–37.
4. Barrett R, Kuzawa CW, McDade T, Armelagos GJ. Emerging and re-
emerging infectious diseases: the third epidemiologic transition. Annu
Rev Anthropol. 1998;27:247–71.
5. Basnyat B, Rajapaksa LC. Cardiovascular and infectious diseases in
South Asia: the double whammy. BMJ. 2004;328:781.
6. Boutayeb A. The double burden of communicable and non-communicable
diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100:
191–9.
7. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P,
Gallimore JR, Pepys MB. Low grade inflammation and coronary heart
disease: prospective study and updated meta-analyses. BMJ. 2000;
321:199–204.
8. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive
protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
JAMA. 2001;286:327–34.
9. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the
metabolic syndrome, and risk of incident cardiovascular events: an
8-Year follow-up of 14 719 initially healthy American women. Cir-
culation. 2003;107:391–7.
10. Kuo H-K, Bean JF, Yen C-J, Leveille SG. Linking C-reactive protein to
late-life disability in the National Health and Nutrition Examination
Survey (NHANES) 1999-2002. J Gerontol A Biol Sci Med Sci. 2006;
61:380–7.
11. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP.
Inflammation biomarkers and near-term death in older men. Am J
Epidemiol. 2007;165:684–95.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;
340:115–26.
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO,
Criqui M, Fadl YY, Fortmann SP, Hong Y, et al. Markers of
inflammation and cardiovascular disease: application to clinical and
public health practice. Circulation. 2003;107:499–511.
14. Adiloglu AK, Can R, Nazli C, Ocal A, Ergene O, Tinaz G, Kisioglu N.
Ectasia and severe atherosclerosis: relationships with Chlamydia
pneumoniae, Helicobacter pylori, and inflammatory markers. Tex
Heart Inst J. 2005;32:21–7.
15. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr,
Sacco RL, Papapanou PN. Periodontal microbiota and carotid intima-
media thickness: the oral infections and vascular disease epidemiology
study (INVEST). Circulation. 2005;111:576–82.
16. Romano Carratelli C, Nuzzo I, Cozzolino D, Bentivoglio C, Paolillo R,
Rizzo A. Relationship between Chlamydia pneumoniae infection,
inflammatory markers, and coronary heart diseases. Int Immunophar-
macol. 2006;6:848–53.
2446 McDade et al.
17. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer
GM, Epstein SE. Effects of total pathogen burden on coronary artery
disease risk and C-reactive protein levels. Am J Cardiol. 2000;85:140–6.
18. Schaffler A, Muller-Ladner U, Scholmerich J, Buchler C. Role of adipose
tissue as an inflammatory organ in human diseases. Endocr Rev. 2006;
27:449–67.
19. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation,
and atherogenesis. Endocrinology. 2003;144:2195–200.
20. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM.
Relationship of total and abdominal adiposity with CRP and IL-6 in
women. Ann Epidemiol. 2003;13:674–82.
21. Adair LS. Dramatic rise in overweight and obesity in adult Filipino
women and risk of hypertension. Obes Res. 2004;12:1335–41.
22. Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD. Prevalence of
metabolic syndrome among Filipino adults aged 20 years and over. Asia
Pac J Clin Nutr. 2003;12:271–6.
23. WHO. The world health report 2004: changing history. Geneva: WHO;
2004.
24. WHO. Mortality country fact sheet 2006. Geneva: WHO; 2006.
25. Adair LS, Kuzawa CW, Borja J. Maternal energy stores and diet
composition during pregnancy program adolescent blood pressure.
Circulation. 2001;104:1034–9.
26. Lohman TG, Roche AF, Martorell R. Anthropometric standardization
reference manual. Champaign (IL): Human Kinetics Books; 1988.
27. Prado MS, Strina A, Barreto ML, Oliveira-Assis AM, Paz LM,
Cairncross S. Risk factors for infection with Giardia duodenalis in
pre-scholl children in the city of Salvador, Brazil. Epidemiol Infect.
2003;131:899–906.
28. Nurgalieva ZZ, Malaty HM, Graham DY, Almuchambetova R,
Machmudova A, Kapsultanova D, Osato MS, Hollinger FB, Zhangabylov
A. Helicobacter pylori infection in Kazakhstan: effect of water source and
household hygiene. Am J Trop Med Hyg. 2002;67:201–6.
29. VanDerslice J, Popkin B, Briscoe J. Drinking-water quality, sanitation,
and breast-feeding: their interactive effects on infant health. Bull World
Health Organ. 1994;72:589–601.
30. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM.
Socioeconomic status and C-reactive protein levels in the US popula-
tion: NHANES IV. Brain Behav Immun. 2006;20:498–504.
31. Gimeno D, Brunner EJ, Lowe GD, Rumley A, Marmot MG, Ferrie JE.
Adult socioeconomic position, C-reactive protein and interleukin-6 in
the Whitehall II prospective study. Eur J Epidemiol. 2007;22:675–83.
32. Dahly DL, Adair LS. Quantifying the urban environment: a scale
measure of urbanicity outperforms the urban-rural dichotomy. Soc Sci
Med. 2007;64:1407–19.
33. Aziz N, Fahey JL, Detels R, Butch AW. Analytical performance of a
highly sensitive C-reactive protein-based immunoassay and the effects
of laboratory variables on levels of protein in blood. Clin Diagn Lab
Immunol. 2003;10:652–7.
34. Ridker PM, Cook N. Clinical usefulness of very high and very low levels
of C-reactive protein across the full range of Framingham risk scores.
Circulation. 2004;109:1955–9.
35. Obesity WHO. Preventing and managing the global epidemic. Genva:
WHO; 2000.
36. Pan W-H, Flegal KM, Chang H-Y, Yeh W-T, Yeh C-J, Lee W-C. Body
mass index and obesity-related metabolic disorders in Taiwanese and US
whites and blacks: implications for definitions of overweight and
obesity for Asians. Am J Clin Nutr. 2004;79:31–9.
37. Razak F, Anand SS, Shannon H, Vuksan V, Davis B, Jacobs R, Teo KK,
McQueen M, Yusuf S. Defining obesity cut points in a multiethnic
population. Circulation. 2007;115:2111–8.
38. WHO. Appropriate body-mass index for Asian populations and its
implications for policy and intervention strategies. Lancet. 2004;363:
157–63.
39. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and
correlates of C-reactive protein concentrations among adult US women.
Clin Chem. 2004;50:574–81.
40. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and
obesity in the United States: prevalence and trends, 1960–1994. Int J
Obes Relat Metab Disord. 1998;22:39–47.
41. Albert MA, Glynn RJ, Buring J, Ridker PM. C-Reactive protein levels
among women of various ethnic groups living in the United States (from
the Women’s Health Study). Am J Cardiol. 2004;93:1238–42.
42. Chandalia M, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM, Abate
N. Elevated plasma high-sensitivity C-reactive protein concentrations in
Asian Indians living in the United States. J Clin Endocrinol Metab.
2003;88:3773–6.
43. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to
body fat distribution and features of the metabolic syndrome in
Europeans and South Asians. Int J Obes Relat Metab Disord. 2001;
25:1327–31.
44. Hak AE, Stehouwer CDA, Bots ML, Polderman KH, Schalkwijk CG,
Westendorp ICD, Hofman A, Witteman JCM. Associations of
C-reactive protein with measures of obesity, insulin resistance, and
subclinical atherosclerosis in healthy, middle-aged women. Arterioscler
Thromb Vasc Biol. 1999;19:1986–91.
45. Araneta MRG, Barrett-Connor E. Ethnic differences in visceral adipose
tissue and type 2 diabetes: Filipino, African-American, and White
Women. Obes Res. 2005;13:1458–65.
46. McDade TW, Leonard WR, Burhop J, Reyes-Garcia V, Vadez V, Huanca
T, Godoy RA. Predictors of C-reactive protein in Tsimane’ 2–15 year-
olds in lowland Bolivia. Am J Phys Anthropol. 2005;128:906–13.
47. Moe CL, Sobsey MD, Samsa GP, Mesolo V. Bacterial indicators of risk
of diarrhoeal disease from drinking water in the Philippines. Bull World
Health Organ. 1991;69:305–17.
48. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes
and its complications: estimates and projections to the year 2010.
Diabet Med. 1997;14:S1–85.
49. Garn H, Renz H. Epidemiological and immunological evidence for the
hygiene hypothesis. Immunobiology. 2007;212:441–52.
50. McDade TW. Life history, maintenance, and the early origins of
immune function. Am J Hum Biol. 2005;17:81–94.
51. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E.
Variability and classification accuracy of serial high-sensitivity
C-reactive protein measurements in healthy adults. Clin Chem. 2001;
47:444–50.
52. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of
C-reactive protein in healthy subjects: implications for reference
intervals and epidemiological applications. Clin Chem. 1997;43:52–8.
Double burden of inflammation in Filipino women 2447
